Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
This week in managed care, the top stories included Atul Gawande, MD, being named the CEO of the Amazon—Berkshire Hathaway–JPMorgan Chase healthcare venture; the Trump administration finalized rules for creating association health plans; an analysis found some cancer types are represented more than others in the Oncology Care Model.
To listen, login to the website.
iTunes: http://apple.co/2eYWTss
TuneIn: http://bit.ly/2gv7iwj
Stitcher: http://bit.ly/2gCqtFg
Listen above or through one of these podcast services:
Amazon, Berkshire Hathaway, JPMorgan Chase Announce CEO of Joint Health Company
New Rule Allows Creation of Association Health Plans That Skirt ACA Regulations, Protections
Participation in OCM May Transform Care for Certain Cancer Types More Quickly Than Others
Implementing Alternative Payment Models for Improved Population Health: Experiences from the OCM
UpWell Health Survey: 45% of Those With Diabetes Skip Care Due to Costs
A Retrospective on the Oncology Care Model
Perspective: FDA/CMS Parallel Review Advances Coverage for Cancer Comprehensive Genomic Profiling
Evidence-Based Oncology—June 2018
Read more about the stories in this podcast:
FDA Approves Danziten for Chronic Myeloid Leukemia Without Mealtime Restrictions
November 14th 2024The FDA has granted approval to Azurity Pharmaceuticals' nilotinib tablets (Danziten), a novel version of the tyrosine kinase inhibitor for chronic myeloid leukemia that can be taken without mealtime restrictions.
Read More